Treatment of stage I lung cancer in high-risk and inoperable patients: Comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033)

Traves Crabtree, Varun Puri, Robert Timmerman, Hiran Fernando, Jeffrey Bradley, Paul A. Decker, Rebecca Paulus, Bryan Meyers

Research output: Contribution to journalReview articlepeer-review

Abstract

This article reviews changes in the roles of surgeons, medical oncologist, and radiation oncologist that have occurred over the past 20 years. A gradual evolution will certainly continue over the next several decades in the multidisciplinary quest to improve the dismal survival results.

Original languageEnglish (US)
Pages (from-to)17-38
Number of pages22
JournalChest Surgery Clinics of North America
Volume11
Issue number1
DOIs
StatePublished - 2001

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Treatment of stage I lung cancer in high-risk and inoperable patients: Comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033)'. Together they form a unique fingerprint.

Cite this